[HTML][HTML] Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis

A Trifan, C Stanciu, I Girleanu, OC Stoica… - World journal of …, 2017 - ncbi.nlm.nih.gov
AIM To perform a systematic review and meta-analysis on proton pump inhibitors (PPIs)
therapy and the risk of Clostridium difficile infection (CDI). METHODS We conducted a …

Prophylaxis against upper gastrointestinal bleeding in hospitalized patients

D Cook, G Guyatt - New England Journal of Medicine, 2018 - Mass Medical Soc
Preventing Gastrointestinal Bleeding in the Hospital Acid suppression is widely used to
lower the risk of gastrointestinal bleeding in critically ill patients, and the practice has spread …

Long‐term use of proton pump inhibitors and prevalence of disease‐and drug‐related reasons for gastroprotection—a cross‐sectional population‐based study

SM Wallerstedt, J Fastbom, J Linke… - … and drug safety, 2017 - Wiley Online Library
Purpose To analyse the prevalence of long‐term use of proton pump inhibitors (PPI) with
respect to underlying diseases and drugs, and to find predictors for such treatment when an …

Germinant synergy facilitates Clostridium difficile spore germination under physiological conditions

TJ Kochan, MS Shoshiev, JL Hastie, MJ Somers… - MSphere, 2018 - Am Soc Microbiol
Clostridium difficile is a Gram-positive obligate anaerobe that forms spores in order to
survive for long periods in the unfavorable environment outside a host. C. difficile is the …

Reducing inappropriate proton pump inhibitors use for stress ulcer prophylaxis in hospitalized patients: systematic review of de-implementation studies

CC Orelio, P Heus, JJ Kroese-van Dieren… - Journal of general …, 2021 - Springer
Background A large proportion of proton pump inhibitor (PPI) prescriptions, including those
for stress ulcer prophylaxis (SUP), are inappropriate. Our study purpose was to …

Appropriateness of proton pump inhibitor prescription in patients admitted to hospital: attitudes of general practitioners and hospital physicians in Italy

F Lodato, E Poluzzi, E Raschi, C Piccinni, A Koci… - European journal of …, 2016 - Elsevier
Introduction Proton pump inhibitor (PPI) prescriptions have raised concern for both huge
increase of health expenditure and possible long-term adverse effects. Objective To …

Outcomes from a pharmacist-led proton pump inhibitor stewardship program at a single institution

RA Wahking, RL Steele, RE Hanners… - Hospital …, 2018 - journals.sagepub.com
Background: Proton pump inhibitors (PPIs) are effective medications for acid-related
disorders; however, they are also overused and may be associated with several adverse …

Potential cardiovascular risks of proton pump inhibitors in the general population

W Zhu, K Hong - International heart journal, 2017 - jstage.jst.go.jp
Proton pump inhibitors (PPIs) are the most effective gastric acid-suppressing agents and the
mainstay medical therapy for a series of acid peptic diseases. In general, the safety profile of …

The impact of pharmacist intervention on the intravenous-to-oral switch therapy of proton pump inhibitors in cardiovascular surgery

J Bao, L Zhou, M Xu, J Ma - Expert Opinion on Drug Safety, 2023 - Taylor & Francis
Background The prescriptions of proton pump inhibitors (PPIs) have been widely concerned
due to both huge increase in medical costs and possible long-term adverse events (AEs) …

Solid oral medications' suitability for use in enteral feeding tubes

K Teder, L Jõhvik, A Meos, M Saar… - Nursing in Critical …, 2022 - Wiley Online Library
Background There is a lack of specific data about the efficacy and safety of medications
administered via feeding tubes, although there is a general awareness that not all drug …